Lobbyists Pushback on Medicare Coverage for Weight-Loss Drugs
Health insurance companies are lobbying the Trump administration to reject Biden-era proposals that would expand Medicare and ...
Patients struggle with lack of consistent coverage for popular weight-loss drugs
Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...
One of the hottest retention factors in 2025 comes with a big cost
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
Merck expects cancer therapy Keytruda to be part of government price setting in 2026
Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government ...
ABC News10d
Weight-loss drugs
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid. A shortage in injections linked to weight loss ...
The American Journal of Managed Care3d
Medicare Part D Spending Trends for Type 2 Diabetes Medications
New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower ...
HME News5d
Spending on diabetes drugs skyrockets, gov’t says
Medicare Part D spending for 10 selected diabetes drugs totaled more than $35.8 billion in 2023, a 364% increase from 2019, according to a new data brief from the Department of Health and Human Servic ...